Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial to Evaluate ET-01 in Subjects With Lateral Canthal Lines

NCT03912805 is registered in ClinicalTrials.gov with Eirion Therapeutics Inc. as lead sponsor.

NCT NCT03912805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03912805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial to Evaluate ET-01 in Subjects With Lateral Canthal Lines
Lead sponsor
Eirion Therapeutics Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 27, 2019
Completion date
October 4, 2019
Enrollment
38 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

crow's feet, lateral canthal lines, lcl